1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Exports
  5. Export of Heparin for Th…

Export of heparin for therapeutic use from Belgium: Diminution in 2017

In 2017 the indicator sharply dropped by 51.53 percent, according to new data issued by United Nations Statistical Office. Pharmaceutical export declined greatly by 6 759 129.5 US Dollar, as it follows the tendency of the previous year when it diminished by 9.42 percent. The overall changes for the prior 19 years hit an increase of 1 424.83%. Though, it has attained a drop at a 0.18 percent compound average annual growth rate during the five years with a modest overall raise since the 1999. It averaged 18 401 062.29 US Dollar from 1999 to 2017 and it attained its all-time high of 100 239 784 US Dollar in 2008 and record low of 416 883 US Dollar in 1999.

Export of heparin for therapeutic use from Belgium: Diminution in 2017
Date US Dollar Variation
2017 6 356 746.50 -51.53
2016 13 115 876.00 -9.42
2015 14 479 240.00 44.68
2014 10 007 774.00 -40.41
2013 16 793 448.00 32.32
2012 12 691 470.00 491.97
2011 2 143 936.00 -84.04
2010 13 437 222.00 -84.27
2009 85 416 296.00 -14.79
2008 100 239 784.00 137.92

Related Statistics

Pharmaceutical Exports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Drug Store Retail Sales

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.